- Home
- LODE vs EPIX Comparison
LODE vs EPIX Comparison
Compare LODE & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LODE
- EPIX
- Stock Information
- Founded
- LODE 2008
- EPIX 2009
- Country
- LODE United States
- EPIX Canada
- Employees
- LODE N/A
- EPIX N/A
- Industry
- LODE Major Chemicals
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- LODE Industrials
- EPIX Health Care
- Exchange
- LODE Nasdaq
- EPIX Nasdaq
- Market Cap
- LODE 74.6M
- EPIX 75.9M
- IPO Year
- LODE N/A
- EPIX N/A
- Fundamental
- Price
- LODE $2.49
- EPIX $1.93
- Analyst Decision
- LODE Hold
- EPIX Hold
- Analyst Count
- LODE 1
- EPIX 3
- Target Price
- LODE $4.00
- EPIX $2.00
- AVG Volume (30 Days)
- LODE 841.2K
- EPIX 474.6K
- Earning Date
- LODE 08-14-2025
- EPIX 08-13-2025
- Dividend Yield
- LODE N/A
- EPIX N/A
- EPS Growth
- LODE N/A
- EPIX N/A
- EPS
- LODE N/A
- EPIX N/A
- Revenue
- LODE $3,280,749.00
- EPIX N/A
- Revenue This Year
- LODE $24.69
- EPIX N/A
- Revenue Next Year
- LODE $740.73
- EPIX N/A
- P/E Ratio
- LODE N/A
- EPIX N/A
- Revenue Growth
- LODE 58.55
- EPIX N/A
- 52 Week Low
- LODE $1.67
- EPIX $1.40
- 52 Week High
- LODE $10.10
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- LODE 34.04
- EPIX 65.49
- Support Level
- LODE $2.24
- EPIX $1.90
- Resistance Level
- LODE $2.51
- EPIX $1.93
- Average True Range (ATR)
- LODE 0.17
- EPIX 0.01
- MACD
- LODE -0.05
- EPIX -0.00
- Stochastic Oscillator
- LODE 20.25
- EPIX 85.71
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.